LEONHARDT VENTURES NEWS
Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation and Differentiation Control
Dec. 20th, 2024 - Irvine, California --(AINewsworthy)-- Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative...
Executive Chairman’s Best guess estimate June 2023 on portfolio assets closest to exit
Executive Chairman's Best guess estimate June 2023 on portfolio assets closest to exit Note - ALL bioelectric products are based on same exact core stimulator with only slightly different signal sequence protocols. Nearly all use our stem cell homing and circulation...
2023 Annual Shareholder Meeting.
Dear Shareholders, Ahead of our 2023 Annual Shareholder Meeting... 1. 2022 Year End Financials https://lventuresnew.wpenginepowered.com/wp-content/uploads/2023/01/12-Dec-2022-Cal-XStarsBusinessAcceleratorInc.Financials-V1-1-17-23.pdf. 2. See 2023 budget attached and...
Episode 138: Howard Leonhardt – The Future of Longevity & Wellness is Here!
The First Lady of Nutrition welcomes Howard Leonhardt, the extraordinary founder of Leonhardt Ventures LLC and Lionheart Health, Inc. Leonhardt Ventures is the world’s first Innovation Accelerator focused on the convergence of bioelectrics & biologics for organ...
1Q 2023 Update Letter to Shareholders for accelerator and portfolio
Published: March 9th, 2023 Mission Viejo and Irvine, Calif., March 9th, 2023 (PRDistribution) -- Dear Stakeholders, Nearly our entire portfolio of startups made great strides in progress in 2022 and are off to great start in early 2023. Here is a link to the...
BodStim Suits Up To Revolutionize Fitness And Shows Significant Promise For Enhancing Longevity
Bioelectrics is poised to be the next frontier of medical technology, and LionHeart Health is developing therapies on several important fronts. by Susan Belknapp, Senior Writer, California Business Journal Klotho. You may not have heard of it, but this protein is...
Industry Veteran Brian Lasater joins Leonhardt Ventures LLC as Chief Technology Officer
NEWS PROVIDED BY Leonhardt Ventures LLC 30th Mar, 2023, 9:00am PT Mission Viejo, CA , March 30th, 2023 /PRDistribution/ -- Leonhardt Ventures LLC announces today that Brian Lasater has joined earlier this year the firm as Chief Technology Officer. In this role, he is...
Second Heart Assist, Inc. Announces Issuance of 20 New U.S. Patent Claims Covering its Circulatory Assist Device Technology Platform
March 16th, 2023, Salt Lake City, Utah and Mission Viejo, CA - Second Heart Assist, Inc. has announced that it has obtained patent no. U.S. 11,602,627 on March 14th, 2023 from the US Patent and Trademark Office Titled “Circulatory Assist Pump” with 20 new patent...
DepressiStim Announces Clinical Trial Progress
DepressiStim TM Reports Progress on Treatment Resistant Depression Pilot Clinical Study The DepressiStim TM Brain Band therapy system is intended to be indicated for adjunctive non-invasive treatment of chronic or recurrent depression in patients who are experiencing...
Leonhardt Ventures Lands 12th Issued Patent for Bioelectric Treatment of Cancers – OPG Control
This new patent letter of allowance received from the USPTO further expands the Company's intellectual property estate intended for treating, suppressing and preventing cancer tumor formation and progression. Leonhardt Ventures LLC and its cancer treating and...